[Therapy of thromboses with low molecular weight heparins]

The most commonly used therapy of thromboembolism consists of continuous intravenous infusions of heparin followed by a treatment with oral anticoagulants. A new aspect of this classical therapy is the possibility of subcutaneous administrations of heparin b.i.d. and, that heparin may be replaced by low molecular weight heparins. The therapy with low molecular weight heparins can be further simplified by only single daily injections and doses regimens which are adjusted to the patient's body weight and which do not require an individual laboratory monitoring.